Michael O'Neill

Michael O'Neill

Eli Lilly and Company - Indianapolis / United States
Others
AD Scientific Index ID: 4387581
-
person_outline Michael O'Neill's MOST POPULAR ARTICLES
1-) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximityZ Ahmed, J Cooper, TK Murray, K Garn, E McNaughton, H Clarke, ...Acta neuropathologica 127 (5), 667-683, 20144282014
2-) Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progressionX Chai, S Wu, TK Murray, R Kinley, CV Cella, H Sims, N Buckner, ...Journal of Biological Chemistry 286 (39), 34457-34467, 20113542011
3-) Impaired glymphatic function and clearance of tau in an Alzheimer’s disease modelIF Harrison, O Ismail, A Machhada, N Colgan, Y Ohene, P Nahavandi, ...Brain 143 (8), 2576-2593, 20203332020
4-) 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase CδK Hanrott, L Gudmunsen, MJ O’Neill, S WonnacottJournal of biological chemistry 281 (9), 5373-5382, 20063262006
5-) Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatmentG De Foubert, SL Carney, CS Robinson, EJ Destexhe, R Tomlinson, ...Neuroscience 128 (3), 597-604, 20043082004